377 related articles for article (PubMed ID: 36443877)
1. Evaluating the frequency and the impact of pharmacogenetic alleles in an ancestrally diverse Biobank population.
Verma SS; Keat K; Li B; Hoffecker G; Risman M; ; Sangkuhl K; Whirl-Carrillo M; Dudek S; Verma A; Klein TE; Ritchie MD; Tuteja S
J Transl Med; 2022 Nov; 20(1):550. PubMed ID: 36443877
[TBL] [Abstract][Full Text] [Related]
2. Prescription Patterns and Relationship to Pharmacogenomics Testing in the Military Health System.
Selig DJ; Livezey JR; Chin GC; DeLuca JP; Guillory Ii WO; Kress AT; Oliver TO; Por ED
Mil Med; 2021 Dec; 187(Suppl 1):9-17. PubMed ID: 34967405
[TBL] [Abstract][Full Text] [Related]
3. How to Run the Pharmacogenomics Clinical Annotation Tool (PharmCAT).
Li B; Sangkuhl K; Keat K; Whaley RM; Woon M; Verma S; Dudek S; Tuteja S; Verma A; Whirl-Carrillo M; Ritchie MD; Klein TE
Clin Pharmacol Ther; 2023 May; 113(5):1036-1047. PubMed ID: 36350094
[TBL] [Abstract][Full Text] [Related]
4. Fetal pharmacogenomics: A promising addition to complex neonatal care.
Raymond M; Critchlow E; Rice SM; Wodoslawsky S; Berger SI; Hegde M; Empey PE; Al-Kouatly HB
Mol Genet Metab; 2022; 137(1-2):140-145. PubMed ID: 36029725
[TBL] [Abstract][Full Text] [Related]
5. Pharmacogenomics implementation in cardiovascular disease in a highly diverse population: initial findings and lessons learned from a pilot study in United Arab Emirates.
Al-Mahayri ZN; Khasawneh LQ; Alqasrawi MN; Altoum SM; Jamil G; Badawi S; Hamza D; George L; AlZaabi A; Ouda H; Al-Maskari F; AlKaabi J; Patrinos GP; Ali BR
Hum Genomics; 2022 Sep; 16(1):42. PubMed ID: 36154845
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of population-level pharmacogenetic actionability in Alabama.
Davis BH; Williams K; Absher D; Korf B; Limdi NA
Clin Transl Sci; 2021 Nov; 14(6):2327-2338. PubMed ID: 34121327
[TBL] [Abstract][Full Text] [Related]
7. Frequencies of pharmacogenomic alleles across biogeographic groups in a large-scale biobank.
Li B; Sangkuhl K; Whaley R; Woon M; Keat K; Whirl-Carrillo M; Ritchie MD; Klein TE
Am J Hum Genet; 2023 Oct; 110(10):1628-1647. PubMed ID: 37757824
[TBL] [Abstract][Full Text] [Related]
8. Assessing Clinical Utility of Pharmacogenetic Testing in the Military Health System.
Hellwig LD; Turner C; Olsen C; Libbus J; Markos B; Koehlmoos T; Haigney M; De Castro M; Saunders D
Mil Med; 2024 Jan; 189(1-2):e198-e204. PubMed ID: 37436924
[TBL] [Abstract][Full Text] [Related]
9. Clinical Utility of Pharmacogenomic Data Collected by a Health-System Biobank to Predict and Prevent Adverse Drug Events.
Shah SN; Gammal RS; Amato MG; Alobaidly M; Reyes DD; Hasan S; Seger DL; Krier JB; Bates DW
Drug Saf; 2021 May; 44(5):601-607. PubMed ID: 33620701
[TBL] [Abstract][Full Text] [Related]
10. Projected impact of a multigene pharmacogenetic test to optimize medication prescribing in cardiovascular patients.
Dong OM; Li A; Suzuki O; Oni-Orisan A; Gonzalez R; Stouffer GA; Lee CR; Wiltshire T
Pharmacogenomics; 2018 Jun; 19(9):771-782. PubMed ID: 29793377
[TBL] [Abstract][Full Text] [Related]
11. Discrepancies and similarities in the genome-informed guidance for psychiatric disorders amongst different regulatory bodies and research consortia using next generation sequencing-based clinical pharmacogenomics data.
Kordou Z; Skokou M; Tsermpini EE; Chantratita W; Fukunaga K; Mushiroda T; Patrinos GP; Koromina M
Pharmacol Res; 2021 May; 167():105538. PubMed ID: 33705851
[TBL] [Abstract][Full Text] [Related]
12. Retrospective Review of Pharmacogenetic Testing at an Academic Children's Hospital.
Roberts TA; Wagner JA; Sandritter T; Black BT; Gaedigk A; Stancil SL
Clin Transl Sci; 2021 Jan; 14(1):412-421. PubMed ID: 33048453
[TBL] [Abstract][Full Text] [Related]
13. Preemptive Pharmacogenomic Testing for Precision Medicine: A Comprehensive Analysis of Five Actionable Pharmacogenomic Genes Using Next-Generation DNA Sequencing and a Customized CYP2D6 Genotyping Cascade.
Ji Y; Skierka JM; Blommel JH; Moore BE; VanCuyk DL; Bruflat JK; Peterson LM; Veldhuizen TL; Fadra N; Peterson SE; Lagerstedt SA; Train LJ; Baudhuin LM; Klee EW; Ferber MJ; Bielinski SJ; Caraballo PJ; Weinshilboum RM; Black JL
J Mol Diagn; 2016 May; 18(3):438-445. PubMed ID: 26947514
[TBL] [Abstract][Full Text] [Related]
14. Prescription medications with actionable pharmacogenomic recommendations in Veterans Health Administration patients.
Maghari S; Gallo T; Rivas S; German A; Nguyen Le MQ; Abbaszadegan H; Zubriski MA; Heise CW; Landas ND
Pharmacogenomics; 2023 Jun; 24(9):501-508. PubMed ID: 37435738
[No Abstract] [Full Text] [Related]
15. Prescribing Prevalence of Medications With Potential Genotype-Guided Dosing in Pediatric Patients.
Ramsey LB; Ong HH; Schildcrout JS; Shi Y; Tang LA; Hicks JK; El Rouby N; Cavallari LH; Tuteja S; Aquilante CL; Beitelshees AL; Lemkin DL; Blake KV; Williams H; Cimino JJ; Davis BH; Limdi NA; Empey PE; Horvat CM; Kao DP; Lipori GP; Rosenman MB; Skaar TC; Teal E; Winterstein AG; Owusu Obeng A; Salyakina D; Gupta A; Gruber J; McCafferty-Fernandez J; Bishop JR; Rivers Z; Benner A; Tamraz B; Long-Boyle J; Peterson JF; Van Driest SL;
JAMA Netw Open; 2020 Dec; 3(12):e2029411. PubMed ID: 33315113
[TBL] [Abstract][Full Text] [Related]
16. Comparison of targeted vs. expanded pharmacogenomic testing: What are we missing?
Chambal M; Forsthoffer C; Egnaczyk A; Seitz M; Grande K; Ashcraft K; Wick JA; Blaxall BC
J Am Pharm Assoc (2003); 2023; 63(3):939-945. PubMed ID: 37024375
[TBL] [Abstract][Full Text] [Related]
17. A retrospective analysis of preemptive pharmacogenomic testing in 22,918 individuals from China.
Huang Q; Liao Y; Yu T; Lei W; Liang H; Wen J; Liu Q; Chen Y; Huang K; Jing L; Huang X; Liu Y; Yu X; Su K; Liu T; Yang L; Huang M
J Clin Lab Anal; 2023 Mar; 37(5):e24855. PubMed ID: 36916827
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of exposure to pharmacogenetic drugs by the Saudis treated at the health care centers of the Ministry of National Guard.
Alshabeeb MA; Alyabsi M; Paras B
Saudi Pharm J; 2022 Aug; 30(8):1181-1192. PubMed ID: 36164570
[TBL] [Abstract][Full Text] [Related]
19. Comparison of FDA Table of Pharmacogenetic Associations and Clinical Pharmacogenetics Implementation Consortium guidelines.
Pritchard D; Patel JN; Stephens LE; McLeod HL
Am J Health Syst Pharm; 2022 Jun; 79(12):993-1005. PubMed ID: 35230418
[TBL] [Abstract][Full Text] [Related]
20. Primary Care Prescription Drug Use and Related Actionable Drug-Gene Interactions in the Danish Population.
Lunenburg CATC; Hauser AS; Ishtiak-Ahmed K; Gasse C
Clin Transl Sci; 2020 Jul; 13(4):798-806. PubMed ID: 32166845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]